920andparticlesizeofmicelleswithtimeuponincubationofthemicellessamplesinSGForSIFat37°C,respectively.TheEEandparticlesizeofmicellesweredeterminedasdescribedearlier.
InVitroReleaseofCyAfromMicelles
OnemilliliterofmicellessolutionwithknownCyAcontentwasplacedintoadialysisbagwithmolecularweightcut-offof50kDa.Thedialysisbagwasimmersedintoa askcontaining30mLofreleasemedium(SGForSIF)con-taining30%(v/v)ethanol(sinkcondition)whichwaskeptinaconstanttemperatureshakingwaterbathat37°Cand100rpm.Atpredeterminedtimeintervals,aliquots(1mL)ofthereleasemediumwastakenandreplacedbyfreshmedium.ThecontentofCyAinthemediumwasmeasuredbyHPLCmethodasdescribedabove.ThecumulativereleasepercentageofCyAwascalculated.IntestinalAbsorption
MaleSDratsweighing200±20gwereusedforthisresearch.Allanimalswerehousedwithfreeaccessstan-dardfoodandtapwater,andexposedtoalternating12hperiodsoflightanddarkness.Temperatureandrelativehumidityweremaintainedat25°Cand50%,respectively.Afteranacclimatizationperiodof2days,theratswerefastedfor12hbutallowedfreeaccesstowaterpriortotheexperiments.Ratswereanaesthetizedviaintraperitonealinjectionof15%w/vurethaneatadoseof1.5g/kgandalaparotomywasperformed.
Insituratperfusionexperiments[32–35]Theabdominalcavitywasopened,andasegmentoftheileumwasexposed.Thesegmentwas ushedwith50mlofwarmKrebs–Ringerbuffersolution[KRB,pH7.4,composedof(inmM):NaCl111.9,KCl5.0,CaCl21.2,MgCl21.2,NaH2PO40.4,Na2HPO41.6,NaHCO325.0,NaGlutamate4.9,NaPyruvate4.9,Na2Fumarate5.4,glucose11.5]toremovetheluminalcontentsandthen ushedwithairtominimizetheamountofluminal uid.Theseratswereplacedinawarmtablefortheabsorptionstudiesaftersurgery.
Theperfusionsolutionwaspreparedusing1mg/mLofCyA-loadedpolymericmicelles(mPEG5-PLA5)orSand-immunNeoralÒinKRBcontaining3-mg/mLphenolred.Phenolredactedasanonabsorbablemarkerintheluminalmediumtocorrecttheappreciablein uenceofthesecretionorabsorptionofwateronCyAcontentduringtheexperi-ment.Arecirculatingsystemwasconstructedbyconnectingasmallreservoircontaining40mLofstirringperfusionsolutionkeptat37°Cwiththeinletcannulaandbydirectingthe owfromtheoutletcannulabacktotheres-ervoir.Theperfusionpump(BT300-300M,Lange,Co,Ltd.
123
NanoscaleResLett(2010)5:917–925
China)wasutilizedtodrivetheperfusateatarateof2mL/minthroughtheinletcannulaintotheintestinalsegment.0.5mLofperfusatesampleswerecollectedandreplacedbyfreshKRBcontaining3-mg/mLphenolredat0.25,0.5,1,2,3,4,6,8hafterperfusion.TheCyAcon-centrationintheperfusatesampleswasmeasuredbyHPLCmethodasdescribedabove,andthephenolredconcentra-tionwasdeterminedusingUVspectrophotometer(Agilent8453,AgilentTechnologies,UK)at558nm.
Exvivoexperiments[29,36]Alaparotomywasper-formedandsegmentofileumwereremovedandusedfortheevertedgutsactechnique.Inbrief,theileumwasrinsedtwicewithsalinesolution(0.9%NaCl)atroomtemperature.ThenthespecimenwasputintooxygenatedTyrodesolution[pH7.4,composedof(inmM):NaCl115,KCl2.7,CaCl21.8,MgCl21.1,NaH2PO40.4,Na2HPO41.6,NaHCO312.7,glucose5.6]immediatelyat37°C.Thentheintestinewasgentlyevertedoveraglassrodanddividedinto5-cmsacswhichwere lledwithfreshoxygenatedTyrodesolutionusingsilksuture.ThesacswereincubatedingentleshakingoxygenatedTyrodesolutioncontainingCyA-loadedpoly-mericmicellesorSandimmunNeoralÒfor120min.Thereafter,theTyrodesolutionwithandwithoutsacswascollected.ThecontentofremainingCyAinthemediumwasmeasuredbyHPLCmethodasdescribedabove.ThemassoftheboundCyAwasdeterminedbysubtractionofthemassofremainingCyAinthemediumfromtheinitialmassofCyAandreportedaspercentbinding:Bindð%Þ
¼ 1À
massofCyAremaininginthemedium
totalmassofCyAloadedmicelleinitiallyused
Â100%:
ThecommercialformulationofCyA,SandimmunNeoralÒ,wasalsotestedascontrol.StatisticalAnalysis
Alldatawereexpressedasmeanstandarddeviation(SD)unlessparticularlyoutlined.Thestatisticalsigni canceofdifferencesamongmorethantwogroupswasdeterminedbyone-wayANOVAbythesoftwareSPSS13.0.Avalueofp\0.05wasconsideredtobesigni cant.
ResultsandDiscussion
CompatibilityBetweenPolymersandtheDrug
Thecompatibilitybetweenadrugandpolymerisknowntobeoneofthekeyfactorsindeterminingtheeffectiveness
[9], at the same time nanocarriers can make the drugs targeted and lower...2.3. Preparation and characterization of drug loaded micelle NPs Micelle NPs...
[9], at the same time nanocarriers can make the drugs targeted and lower...2.3. Preparation and characterization of drug loaded micelle NPs Micelle NPs...
热门文档